Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.92
-0.30 (-3.65%)
At close: Apr 24, 2026, 4:00 PM EDT
7.89
-0.03 (-0.38%)
After-hours: Apr 24, 2026, 7:57 PM EDT
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $779.29 million as of April 24, 2026. Its market cap has increased by 276.65% in one year.
Market Cap
779.29M
Enterprise Value
612.60M
1-Year Change
276.65%
Ranking
Category
Stock Price
$7.92
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has increased from $754.10M to $779.29M, an increase of 3.34%. That is a compound annual growth rate of 0.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 808.80M | 84.07% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 827.15M |
| Crescent Biopharma | 824.37M |
| ARS Pharmaceuticals | 823.17M |
| Kura Oncology | 821.94M |
| SELLAS Life Sciences Group | 800.94M |
| Cullinan Therapeutics | 800.16M |
| Allogene Therapeutics | 794.59M |
| SpyGlass Pharma | 786.19M |